Association of IL-17 polymorphisms with gastric cancer risk in Asian populations

World Journal of Gastroenterology

Volumn 21, Issue 18, 2015, Pages 5707-5718

  Long, Zi Wen ^a,b   Yu, Hong Mei ^a,b   Wang, Ya Nong ^a,b   Liu, Dan ^a   Chen, Yan Zhi ^a   Zhao, Yu Xia ^a   Bai, Lu ^b  

^a FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Asian populations; Gastric cancer; Genetic polymorphism; IL 17; Meta analysis

Indexed keywords

INTERLEUKIN 17;

ARTICLE; ASIAN; CANCER PATIENT; CANCER RISK; CANCER SUSCEPTIBILITY; CASE CONTROL STUDY; CHINESE; CINAHL; COCHRANE LIBRARY; DNA POLYMORPHISM; EMBASE; GENETIC MODEL; HUMAN; INVESTIGATIVE PROCEDURES; JAPANESE (PEOPLE); MEDLINE; META ANALYSIS; RISK FACTOR; SCISEARCH; STOMACH CANCER; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; EPIDEMIOLOGY; ETHNOLOGY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; ODDS RATIO; PHENOTYPE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH NEOPLASMS;

ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-17; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84929223852     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i18.5707     Document Type: Article

References (40)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90 [PMID: 21296855 doi: 10.3322/caac.20107]
2. Qinghai Z, Yanying W, Yunfang C, Xukui Z, Xiaoqiao Z. Effect of interleukin-17A and interleukin-17F gene polymorphisms on the risk of gastric cancer in a Chinese population. Gene 2014; 537: 328-332 [PMID: 24315816 doi: 10.1016/j.gene.2013.11.007]
3. Tahara T, Shibata T, Nakamura M, Yamashita H, Yoshioka D, Okubo M, Yonemura J, Maeda Y, Maruyama N, Kamano T, Kamiya Y, Fujita H, Nakagawa Y, Nagasaka M, Iwata M, Hirata I, Arisawa T. Association between IL-17A,-17F and MIF polymorphisms predispose to CpG island hyper-methylation in gastric cancer. Int J Mol Med 2010; 25: 471-477 [PMID: 20127054]
4. Li Y, Yang Y, Lu Y, Herman JG, Brock MV, Zhao P, Guo M. Predictive value of CHFR and MLH1 methylation in human gastric cancer. Gastric Cancer 2015; 18: 280-287 [PMID: 24748501 DOI: 10.1007/s10120-014-0370-2]
5. Meng XY, Zhou CH, Ma J, Jiang C, Ji P. Expression of interleukin-17 and its clinical significance in gastric cancer patients. Med Oncol 2012; 29: 3024-3028 [PMID: 22744708 doi: 10.1007/s12032-012-0273-1]
6. Caruso R, Pallone F, Monteleone G. Emerging role of IL-23/IL-17 axis in H pylori-associated pathology. World J Gastroenterol 2007; 13: 5547-5551 [PMID: 17948927]
7. Rafiei A, Hosseini V, Janbabai G, Ghorbani A, Ajami A, Farzmandfar T, Azizi MD, Gilbreath JJ, Merrell DS. Polymorphism in the interleukin-17A promoter contributes to gastric cancer. World J Gastroenterol 2013; 19: 5693-5699 [PMID: 24039363 doi: 10.3748/wjg.v19.i34.5693]
8. Peng SF, Wang SJ, Chen JG, Dai XL, Shi Y, Li YZ, Su ZL, Xue Y, He ZQ, Huang XX, Xu HX. [Detection and significance of transcription factors and cytokines of Th17/Treg cells in peripheral blood in the gastric cancer patients]. Zhonghua Zhong Liu Za Zhi 2010; 32: 185-189 [PMID: 20450585]
9. Yao Z, Painter SL, Fanslow WC, Ulrich D, Macduff BM, Spriggs MK, Armitage RJ. Human IL-17: a novel cytokine derived from T cells. J Immunol 1995; 155: 5483-5486 [PMID: 7499828]
10. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 2003; 14: 155-174 [PMID: 12651226]
11. Ciric B, El-behi M, Cabrera R, Zhang GX, Rostami A. IL-23 drives pathogenic IL-17-producing CD8+ T cells. J Immunol 2009; 182: 5296-5305 [PMID: 19380776 doi: 10.4049/jimmunol.0900036]
12. Chen JG, Xia JC, Liang XT, Pan K, Wang W, Lv L, Zhao JJ, Wang QJ, Li YQ, Chen SP, He J, Huang LX, Ke ML, Chen YB, Ma HQ, Zeng ZW, Zhou ZW, Chang AE, Li Q. Intratumoral expression of IL-17 and its prognostic role in gastric adenocarcinoma patients. Int J Biol Sci 2011; 7: 53-60 [PMID: 21234303]
13. Carlson MJ, West ML, Coghill JM, Panoskaltsis-Mortari A, Blazar BR, Serody JS. In vitro-differentiated TH17 cells mediate lethal acute graft-versus-host disease with severe cutaneous and pulmonary pathologic manifestations. Blood 2009; 113: 1365-1374 [PMID: 18957685 doi: 10.1182/blood-2008-06-162420]
14. Awasthi A, Kuchroo VK. Th17 cells: from precursors to players in inflammation and infection. Int Immunol 2009; 21: 489-498 [PMID: 19261692 doi: 10.1093/intimm/dxp021]
15. Bedoya SK, Lam B, Lau K, Larkin J. Th17 cells in immunity and autoimmunity. Clin Dev Immunol 2013; 2013: 986789 [PMID: 24454481 doi: 10.1155/2013/986789]
16. Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M, Naka T, Ojima T, Ueda K, Hayata K, Nakamura Y, Yamaue H. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer. Oncol Rep 2011; 25: 1271-1277 [PMID: 21369705 DOI: 10.3892/or.2011.1201]
17. Zarogoulidis P, Katsikogianni F, Tsiouda T, Sakkas A, Katsikogiannis N, Zarogoulidis K. Interleukin-8 and interleukin-17 for cancer. Cancer Invest 2014; 32: 197-205 [PMID: 24669909 DOI: 10.3109/07357907.2014.898156]
18. Xu C, Hao K, Yu L, Zhang X. Serum interleukin-17 as a diagnostic and prognostic marker for non-small cell lung cancer. Biomarkers 2014; 19: 287-290 [PMID: 24731052 doi: 10.3109/1354750X.201 4.908954]
19. Ishigame H, Kakuta S, Nagai T, Kadoki M, Nambu A, Komiyama Y, Fujikado N, Tanahashi Y, Akitsu A, Kotaki H, Sudo K, Nakae S, Sasakawa C, Iwakura Y. Differential roles of interleukin-17A and-17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 2009; 30: 108-119 [PMID: 19144317 doi: 10.1016/j.immuni.2008.11.009]
20. Shibata T, Tahara T, Hirata I, Arisawa T. Genetic polymorphism of interleukin-17A and-17F genes in gastric carcinogenesis. Hum Immunol 2009; 70: 547-551 [PMID: 19414056 doi: 10.1016/ j.humimm.2009.04.030]
21. Iida T, Iwahashi M, Katsuda M, Ishida K, Nakamori M, Nakamura M, Naka T, Ojima T, Ueda K, Hayata K, Yasuoka H, Yamaue H. Prognostic significance of IL-17 mRNA expression in peritoneal lavage in gastric cancer patients who underwent curative resection. Oncol Rep 2014; 31: 605-612 [PMID: 24337702 doi: 10.3892/ or.2013.2911]
22. Murugaiyan G, Saha B. Protumor vs antitumor functions of IL-17. J Immunol 2009; 183: 4169-4175 [PMID: 19767566 doi: 10.4049/ jimmunol.0901017]
23. Zhang X, Zheng L, Sun Y, Zhang X. Analysis of the association of interleukin-17 gene polymorphisms with gastric cancer risk and interaction with Helicobacter pylori infection in a Chinese population. Tumour Biol 2014; 35: 1575-1580 [PMID: 24218334 doi: 10.1007/s13277-013-1217-x]
24. Van Cutsem E, Dicato M, Geva R, Arber N, Bang Y, Benson A, Cervantes A, Diaz-Rubio E, Ducreux M, Glynne-Jones R, Grothey A, Haller D, Haustermans K, Kerr D, Nordlinger B, Marshall J, Minsky BD, Kang YK, Labianca R, Lordick F, Ohtsu A, Pavlidis N, Roth A, Rougier P, Schmoll HJ, Sobrero A, Tabernero J, Van de Velde C, Zalcberg J. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010. Ann Oncol 2011; 22 Suppl 5: v1-v9 [PMID: 21633049 doi: 10.1093/annonc/ mdr284]
25. da Costa BR, Cevallos M, Altman DG, Rutjes AW, Egger M. Uses and misuses of the STROBE statement: bibliographic study. BMJ Open 2011; 1: e000048 [PMID: 22021739 doi: 10.1136/ bmjopen-2010-000048]
26. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in metaanalysis. JAMA 2006; 295: 676-680 [PMID: 16467236 DOI: 10.1001/jama.295.6.676]
27. Jackson D, White IR, Riley RD. Quantifying the impact of betweenstudy heterogeneity in multivariate meta-analyses. Stat Med 2012; 31: 3805-3820 [PMID: 22763950 doi: 10.1002/sim.5453]
28. Zintzaras E, Ioannidis JP. HEGESMA: genome search metaanalysis and heterogeneity testing. Bioinformatics 2005; 21: 3672-3673 [PMID: 15955784 doi: 10.1093/bioinformatics/bti536]
29. Arisawa T, Tahara T, Shiroeda H, Matsue Y, Minato T, Nomura T, Yamada H, Hayashi R, Saito T, Matsunaga K, Fukuyama T, Hayashi N, Otsuka T, Fukumura A, Nakamura M, Shibata T. Genetic polymorphisms of IL17A and pri-microRNA-938, targeting IL17A 3'-UTR, influence susceptibility to gastric cancer. Hum Immunol 2012; 73: 747-752 [PMID: 22537748 doi: 10.1016/ j.humimm.2012.04.011]
30. Wu XQ, Zeng ZR, Xu LX, Yu J, Cao QH, Xue L, Hao YT, Chen MH, Hu PJ. Association of interleukin-17 G197A gene polymorphism and interleukin-17 expression with gastric cancer. J Practical Med 2014; 30: 246-249 [doi: 10.3969/j.issn.1006-5725.2014.02.029]
31. Zeng ZR, Wu XQ, Xu LX, Yu J, Xue L, Hao YT, Wang YM, Chen MH, Hu PJ. Association between polymorphism of interleukin-17F A7488G and gastric cancer in Guangdong province of China. Zhonghua Xiaohua Zazhi 2010; 30: 507-511 [doi: 10.3760/cma. j.issn.0254-1432.2010.08.002]
32. Zhang FF, Terry MB, Hou L, Chen J, Lissowska J, Yeager M, Zatonski W, Chanock S, Morabia A, Chow WH. Genetic polymorphisms in folate metabolism and the risk of stomach cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 115-121 [PMID: 17220339 doi: 10.1158/1055-9965.EPI-06-0513]
33. Zhu X, Mulcahy LA, Mohammed RA, Lee AH, Franks HA, Kilpatrick L, Yilmazer A, Paish EC, Ellis IO, Patel PM, Jackson AM. IL-17 expression by breast-cancer-associated macrophages: IL-17 promotes invasiveness of breast cancer cell lines. Breast Cancer Res 2008; 10: R95 [PMID: 19014637 doi: 10.1186/bcr2195]
34. Lan C, Huang X, Lin S, Huang H, Cai Q, Lu J, Liu J. High density of IL-17-producing cells is associated with improved prognosis for advanced epithelial ovarian cancer. Cell Tissue Res 2013; 352: 351-359 [PMID: 23397428 doi: 10.1007/s00441-013-1567-0]
35. Straus DS. TNFα and IL-17 cooperatively stimulate glucose metabolism and growth factor production in human colorectal cancer cells. Mol Cancer 2013; 12: 78 [PMID: 23866118 DOI: 10.1186/1476-4598-12-78]
36. Wu X, Zeng Z, Chen B, Yu J, Xue L, Hao Y, Chen M, Sung JJ, Hu P. Association between polymorphisms in interleukin-17A and interleukin-17F genes and risks of gastric cancer. Int J Cancer 2010; 127: 86-92 [PMID: 19904747 doi: 10.1002/ijc.25027]
37. Caruso R, Fina D, Paoluzi OA, Del Vecchio Blanco G, Stolfi C, Rizzo A, Caprioli F, Sarra M, Andrei F, Fantini MC, MacDonald TT, Pallone F, Monteleone G. IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur J Immunol 2008; 38: 470-478 [PMID: 18200634 doi: 10.1002/eji.200737635]
38. Miossec P, Korn T, Kuchroo VK. Interleukin-17 and type 17 helper T cells. N Engl J Med 2009; 361: 888-898 [PMID: 19710487 DOI: 10.1056/NEJMra0707449]
39. Shen F, Gaffen SL. Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy. Cytokine 2008; 41: 92-104 [PMID: 18178098 doi: 10.1016/ j.cyto.2007.11.013]
40. Kawaguchi M, Takahashi D, Hizawa N, Suzuki S, Matsukura S, Kokubu F, Maeda Y, Fukui Y, Konno S, Huang SK, Nishimura M, Adachi M. IL-17F sequence variant (His161Arg) is associated with protection against asthma and antagonizes wild-type IL-17F activity. J Allergy Clin Immunol 2006; 117: 795-801 [PMID: 16630936 DOI: 10.1016/j.jaci.2005.12.1346]